3rd Quarter - Report

BRAVO GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Biopharmaceutical issues including colon, social and economic, value of the biopharmaceutical sector, patient access and safety issues, life science innovation, and job impact.

LobbyistCovered position, as disclosed
CHRIS BRAVACOS —
TED PIPER —
JENNIFER LAURA RILEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.